Ascletis Pharma Inc. (1672.HK) HKSE
9.94
-0.39(-3.78%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 9.95B |
| Enterprise Value | 8.51B |
| P/E Ratio | -23.78 |
| PEG Ratio | 0.69 |
| Price/Sales Ratio | 4,531.88 |
| Price/Book Ratio | 4.42 |
| Enterprise/Revenue | 3,822.33 |
| Enterprise/EBITDA | -16.44 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -177.46 |
| Operating Margin | -238.54 |
Management Effectiveness
| Return On Assets | -0.17 |
| Return On Equity | -0.19 |
Income Statement
| Revenue | 2.03M |
| Revenue/Share | 0 |
| Gross Profit | 527,000 |
| EBITDA | -471.65M |
| Net Income | -359.88M |
| Diluted EPS | -0.37 |
Balance Sheet
| Total Cash | 1.9B |
| Total Cash/Share | 1.94 |
| Total Debt | 5.16M |
| Total Debt/Equity | 0 |
| Current Ratio | 15.05 |
| Book Value Per Share | 1.97 |
Price History
| 52-Week Change | 26.44 |
| 52-Week High | 19.86 |
| 52-Week Low | 7.22 |
| Moving Average 50 Days | 16.43 |
| Moving Average 200 Days | 13.83 |
Statistics
| Average Volume | 2.49M |
| Shares Outstanding | 1.06B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
